San Jose, California (PRWEB) August 08, 2014
Key players covered in the report include Abbott Animal Health, Bayer HealthCare, Boehringer Ingelheim GmbH, Ceva Sant Animale S.A., Dechra Pharmaceuticals PLC, Eli Lilly and Company, Merck Animal Health, Merial Limited, Novartis Animal Health Inc., Vetericyn Inc., Vtoquinol SA, Virbac SA, and Zoetis Inc. among others.
The research report titled, “Animal Medication: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, major growth drivers, regulations, issues, challenges, mergers and acquisitions, and other strategic industry activities of players worldwide. The report provides market estimates and projections in dollars for all major geographic markets, including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Rest of World. Product segments analyzed include Farm Animal Medication Products (Cattle, Pigs, and Others), and Companion Animal Medication. The study also analyzes different product groups for the global market, including Parasiticides, Vaccines, Anti-infectives, Medicinal Feed Additives, and other Pharmaceuticals.
About Global Industry Analysts, Inc.:
Global Industry Analysts, Inc. (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today as one of the world’s largest and reputed market research firms.